More promising results have been released in the search for a COVID-19 vaccine.
Massachusetts-based biotechnology company, Moderna, annouced this week that it’s vaccine is 94 percent effective in stopping the virus in clinical trials.
This just on the heels of Pfizer’s announcement last week with similar findings. Still, there is a large concern as to how the vaccine will be stored and distributed in Hawaii safely and effectively.
Both Moderna and Pfizer’s vaccines are made of messenger RNA or mRNA, which is fragile. Pfizer’s vaccine must be deep frozen at negative 94 degrees fahrenheit, which would usually require dry ice.
Moderna’s vaccine needs to be frozen at negative 4 degrees fahrenheit, which is a common temperature for most freezers.